Actinogen Medical Ltd (3AC) Stock Price & News

All values in AUD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	937.07K	937.07K	5.40M	5.40M
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	4.45M	4.45M	5.06M	5.06M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.56M	1.56M	1.91M	1.91M
Operating expense	6.64M	6.64M	7.42M	7.42M
Total operating expenses	6.64M	6.64M	7.42M	7.42M
Operating income	-5.70M	-5.70M	-2.02M	-2.02M
Other non operating income	-	-	-	-
EBT including unusual items	-5.67M	-5.67M	-2.02M	-2.02M
EBT excluding unusual items	-5.67M	-5.67M	-2.02M	-2.02M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-5.67M	-5.67M	-2.02M	-2.02M
Net profit margin	-605.45%	-605.45%	-37.34%	-37.34%
Earnings per share	-	-	-	-
Interest and investment income	116.46K	116.46K	133.47K	133.47K
Interest expense	-76.33K	-76.33K	-156.64K	-156.64K
Net interest expenses	40.13K	40.13K	-23.17K	-23.17K
Depreciation and amortization charges	27.15K	27.15K	26.11K	26.11K
EBITDA	-5.62M	-5.62M	-1.93M	-1.93M
Gain or loss from assets sale	-	-	-	-

Finance